New research presented at the 2025 American Society for Clinical Oncology’s (ASCO) annual meeting has shed light on the ...

Cullinan Therapeutics has announced a licensing agreement with Genrix Bio for global rights to velinotamig, a clinical-stage ...

Under the new law, anyone in Montana can legally access drugs that have passed just one phase 1 clinical trial.

With a new law that makes it easier for people to access experimental treatments, Montana could become the hub for the ...

Novocure NVCR recently announced positive top-line results from its pivotal Phase 3 PANOVA-3 trial, evaluating Tumor Treating ...

Background: Clinical trial designs have historically been biased towards the Caucasian population, with limited ...

Although osteoarthritis is receiving more attention in both the research and clinical arenas than ever, all that attention ...

- Scientific Advisory Board brings together distinguished experts in neuroscience to support Denovo's CNS development programs, including the Phase 3-ready lead program, biomarker-guided DB104 ...

The African Medical Centre of Excellence (AMCE) officially opened today, marking a historic milestone in Africa's journey ...

BDC-4182 Phase 1 dose-escalation study now open for enrollmentBDC-3042 Phase 1 dose-escalation data presented at AACR 2025 demonstrated a favorable safety profile, dose-dependent biological activity ...

Patients with metastatic castration-sensitive prostate cancer (mCSPC), who have specific genetic mutations, were found to ...

Explore how psilocybin-assisted therapy could revolutionize treatment for Body Dysmorphic Disorder (BDD) by promoting ...